Granulox for managing chronic non-healing wounds

Equality considerations

NICE is committed to promoting equality of opportunity, eliminating unlawful discrimination and fostering good relations between people with particular protected characteristics and others.

Granulox is intended to be used by people with chronic non-healing wounds such as diabetic foot ulcers, venous leg ulcers and pressure ulcers. Older people, people with heart conditions and people with diabetes are more likely to have diabetic foot ulcers and other chronic non-healing wounds and may benefit from this technology. Granulox is contraindicated for use in people who are pregnant. Age, disability and pregnancy are protected characteristics under the Equality Act 2010.

The production of Granulox uses haemoglobin taken from pigs. People with certain religious or philosophical beliefs may not use products derived from pigs. The company has a letter from the Muslim Council of Britain that states that porcine products may be acceptable for medical use when no other alternative is found. Religious and philosophical beliefs are protected characteristics under the Equality Act 2010.